VRNA Verona Pharma Inc.: שווי הפעילות העסקית

The Verona Pharma plc (VRNA) price chart reflects a business valuation that currently stands at . Verona Pharma plc operates as a lean scientific team, outsourcing its production and testing. The firm maintains significant authority in treating lung diseases by implementing cutting-edge therapeutic methods. However, the brand's financial stability relies solely on a single inhalation product, creating a critical dependency on its market success.

The dynamics of this multiple allow for an objective assessment of the business's investment value by combining market capitalization with net debt to determine the actual cost of acquiring the asset. By analyzing the total enterprise value including net debt, an investor sees the actual price of Verona Pharma (VRNA), which is critically dependent on external contractors (CRO/CMO) due to a lack of in-house manufacturing capacities.